 | • レポートコード：MRC2304F107 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、224ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：医療 |
| Single User（1名利用、印刷可） | ￥732,452 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,472,452 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社の本調査レポートによると、2021年に207.6億ドルであった世界の創傷ケア市場規模は2022年に217.9億ドルになり、更に年平均5.14％拡大して2027年までに280.6億ドルに達する見通しです。本書は、創傷ケアの世界市場についての多面的な調査を元に、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、製品別（先進創傷被覆材、生理活性物質、陰圧閉鎖療法、従来型創傷ケア製品）分析、装置別（電気刺激装置、高圧酸素装置、圧力逃がし装置、陰圧創傷治療システム、その他創傷治療装置）分析、種類別（急性創傷、慢性創傷）分析、エンドユーザー別（在宅医療、病院、専門クリニック、外傷センター）分析、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）分析、競争状況、企業情報などの内容をまとめた市場調査レポートです。なお、本書に掲載されている企業情報には、Acelity (KCI Licensing, Inc.)、ACell Inc、Advancis Medical USA LLC、B. Braun Melsungen AG、Baxter International Inc.、Cardinal Health Inc.、Coloplast A/S、Coloplast Corp.、ConvaTec Group PLC、Derma Sciences, Inc.、DeRoyal Industriesなどが含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界の創傷ケア市場規模：製品別 - 先進創傷被覆材の市場規模 - 生理活性物質の市場規模 - 陰圧閉鎖療法の市場規模 - 従来型創傷ケア製品の市場規模 ・世界の創傷ケア市場規模：装置別 - 電気刺激装置の市場規模 - 高圧酸素装置の市場規模 - 圧力逃がし装置の市場規模 - 陰圧創傷治療システムの市場規模 - その他創傷治療装置の市場規模 ・世界の創傷ケア市場規模：種類別 - 急性創傷の市場規模 - 慢性創傷の市場規模 ・世界の創傷ケア市場規模：エンドユーザー別 - 在宅医療における市場規模 - 病院における市場規模 - 専門クリニックにおける市場規模 - 外傷センターにおける市場規模 ・世界の創傷ケア市場規模：地域別 - 南北アメリカの創傷ケア市場規模 アメリカの創傷ケア市場規模 カナダの創傷ケア市場規模 ブラジルの創傷ケア市場規模 ... - アジア太平洋の創傷ケア市場規模 日本の創傷ケア市場規模 中国の創傷ケア市場規模 インドの創傷ケア市場規模 韓国の創傷ケア市場規模 台湾の創傷ケア市場規模 ... - ヨーロッパ/中東/アフリカの創傷ケア市場規模 イギリスの創傷ケア市場規模 ドイツの創傷ケア市場規模 フランスの創傷ケア市場規模 ロシアの創傷ケア市場規模 ... - その他地域の創傷ケア市場規模 ・競争状況 ・企業情報 |
The Global Wound Care Market size was estimated at USD 20.76 billion in 2021 and expected to reach USD 21.79 billion in 2022, and is projected to grow at a CAGR 5.14% to reach USD 28.06 billion by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Wound Care to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Product, the market was studied across Advanced Wound Dressing, Bioactives, Negative Pressure Wound Therapy, Others, and Traditional Wound Care Products.
Based on Devices, the market was studied across Electric Stimulation Devices, Hyperbaric Oxygen Equipment, LPressure Relief Devices, Negative Pressure Wound Therapy Systems, Other Wound Therapy Devices, and Oxygen & Hyperbaric Oxygen Equipment.
Based on Type, the market was studied across Acute wound and Chronic wound.
Based on End User, the market was studied across Home Healthcare, Hospitals, Others, Specialty Clinics, and Trauma Centers.
Based on Application, the market was studied across Acute Wounds and Chronic Wounds. The Acute Wounds is further studied across Burn Wounds and Surgical & Traumatic Wounds. The Chronic Wounds is further studied across Diabetic Foot Ulcers, Other Chronic Wounds, Pressure Ulcers, and Venous Leg Ulcers.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Wound Care market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Wound Care Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Wound Care Market, including Acelity (KCI Licensing, Inc.), ACell Inc, Advancis Medical USA LLC, B. Braun Melsungen AG, Baxter International Inc., Cardinal Health Inc., Coloplast A/S, Coloplast Corp., ConvaTec Group PLC, Derma Sciences, Inc., DeRoyal Industries, Ethicon Inc. (Johnson & Johnson), Haromed BVBA, Integra LifeSciences Holdings Corporation, Kerecis hf, Lohmann & Rauscher International GmbH & Co., Medela AG, Medline Industries, Inc., Medtronic PLC, MiMedx Group, Mölnlycke Health Care AB, Organogenesis Holdings Inc, PAUL HARTMANN AG, Smith & Nephew PLC, The 3M Company, and Zimmer Biomet Holdings.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Wound Care Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Wound Care Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Wound Care Market?
4. What is the competitive strategic window for opportunities in the Global Wound Care Market?
5. What are the technology trends and regulatory frameworks in the Global Wound Care Market?
6. What is the market share of the leading vendors in the Global Wound Care Market?
7. What modes and strategic moves are considered suitable for entering the Global Wound Care Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising geriatric population
5.1.1.2. High prevalence of diabetes and cases of obesity population
5.1.1.3. Increasing cases of traumatic wounds
5.1.1.4. Technology advancements for faster recovery
5.1.2. Restraints
5.1.2.1. High cost advanced wound care devices
5.1.2.2. Absence of standards in wound care management
5.1.3. Opportunities
5.1.3.1. Growth in number of Ambulatory Surgical Centers (ASCs)
5.1.3.2. Regenerative medicine applications in wound care
5.1.4. Challenges
5.1.4.1. Limited reach in developing countries
5.1.4.2. Complexity of wound environment due to patients comorbidity
5.2. Cumulative Impact of COVID-19
6. Wound Care Market, by Product
6.1. Introduction
6.2. Advanced Wound Dressing
6.3. Bioactives
6.4. Negative Pressure Wound Therapy
6.5. Others
6.6. Traditional Wound Care Products
7. Wound Care Market, by Devices
7.1. Introduction
7.2. Electric Stimulation Devices
7.3. Hyperbaric Oxygen Equipment
7.4. LPressure Relief Devices
7.5. Negative Pressure Wound Therapy Systems
7.6. Other Wound Therapy Devices
7.7. Oxygen & Hyperbaric Oxygen Equipment
8. Wound Care Market, by Type
8.1. Introduction
8.2. Acute wound
8.3. Chronic wound
9. Wound Care Market, by End User
9.1. Introduction
9.2. Home Healthcare
9.3. Hospitals
9.4. Others
9.5. Specialty Clinics
9.6. Trauma Centers
10. Wound Care Market, by Application
10.1. Introduction
10.2. Acute Wounds
10.3.1. Burn Wounds
10.3.2. Surgical & Traumatic Wounds
10.3. Chronic Wounds
10.4.1. Diabetic Foot Ulcers
10.4.2. Other Chronic Wounds
10.4.3. Pressure Ulcers
10.4.4. Venous Leg Ulcers
11. Americas Wound Care Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Wound Care Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Wound Care Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.1.1. Quadrants
14.1.2. Business Strategy
14.1.3. Product Satisfaction
14.2. Market Ranking Analysis, By Key Player
14.3. Market Share Analysis, By Key Player
14.4. Competitive Scenario
14.4.1. Merger & Acquisition
14.4.2. Agreement, Collaboration, & Partnership
14.4.3. New Product Launch & Enhancement
14.4.4. Investment & Funding
14.4.5. Award, Recognition, & Expansion
15. Company Usability Profiles
15.1. Acelity (KCI Licensing, Inc.)
15.1.1. Business Overview
15.1.2. Key Executives
15.1.3. Product & Services
15.2. ACell Inc
15.2.1. Business Overview
15.2.2. Key Executives
15.2.3. Product & Services
15.3. Advancis Medical USA LLC
15.3.1. Business Overview
15.3.2. Key Executives
15.3.3. Product & Services
15.4. B. Braun Melsungen AG
15.4.1. Business Overview
15.4.2. Key Executives
15.4.3. Product & Services
15.5. Baxter International Inc.
15.5.1. Business Overview
15.5.2. Key Executives
15.5.3. Product & Services
15.6. Cardinal Health Inc.
15.6.1. Business Overview
15.6.2. Key Executives
15.6.3. Product & Services
15.7. Coloplast A/S
15.7.1. Business Overview
15.7.2. Key Executives
15.7.3. Product & Services
15.8. Coloplast Corp.
15.8.1. Business Overview
15.8.2. Key Executives
15.8.3. Product & Services
15.9. ConvaTec Group PLC
15.9.1. Business Overview
15.9.2. Key Executives
15.9.3. Product & Services
15.10. Derma Sciences, Inc.
15.10.1. Business Overview
15.10.2. Key Executives
15.10.3. Product & Services
15.11. DeRoyal Industries
15.11.1. Business Overview
15.11.2. Key Executives
15.11.3. Product & Services
15.12. Ethicon Inc. (Johnson & Johnson)
15.12.1. Business Overview
15.12.2. Key Executives
15.12.3. Product & Services
15.13. Haromed BVBA
15.13.1. Business Overview
15.13.2. Key Executives
15.13.3. Product & Services
15.14. Integra LifeSciences Holdings Corporation
15.14.1. Business Overview
15.14.2. Key Executives
15.14.3. Product & Services
15.15. Kerecis hf
15.15.1. Business Overview
15.15.2. Key Executives
15.15.3. Product & Services
15.16. Lohmann & Rauscher International GmbH & Co.
15.16.1. Business Overview
15.16.2. Key Executives
15.16.3. Product & Services
15.17. Medela AG
15.17.1. Business Overview
15.17.2. Key Executives
15.17.3. Product & Services
15.18. Medline Industries, Inc.
15.18.1. Business Overview
15.18.2. Key Executives
15.18.3. Product & Services
15.19. Medtronic PLC
15.19.1. Business Overview
15.19.2. Key Executives
15.19.3. Product & Services
15.20. MiMedx Group
15.20.1. Business Overview
15.20.2. Key Executives
15.20.3. Product & Services
15.21. Mölnlycke Health Care AB
15.21.1. Business Overview
15.21.2. Key Executives
15.21.3. Product & Services
15.22. Organogenesis Holdings Inc
15.22.1. Business Overview
15.22.2. Key Executives
15.22.3. Product & Services
15.23. PAUL HARTMANN AG
15.23.1. Business Overview
15.23.2. Key Executives
15.23.3. Product & Services
15.24. Smith & Nephew PLC
15.24.1. Business Overview
15.24.2. Key Executives
15.24.3. Product & Services
15.25. The 3M Company
15.25.1. Business Overview
15.25.2. Key Executives
15.25.3. Product & Services
15.26. Zimmer Biomet Holdings
15.26.1. Business Overview
15.26.2. Key Executives
15.26.3. Product & Services
16. Appendix
16.1. Discussion Guide
16.2. License & Pricing